Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Rhythm Biosciences.
RELATED STOCKHEAD STORIES
News
ASX Small Caps Lunch Wrap: No rest for ASX on Labour Day as benchmark inches higher
Health & Biotech
National biotech summit shows off a wealth of healthcare and medical innovation
News
Rise and Shine: Everything you need to know before the ASX opens
News
In Case You Missed It: A Medicare win and director resignations round out the year
News
Top 10 at 11: Hefty moves by some hefty companies are making waves this morning
Health & Biotech
ASX Health Stocks: Rhythm Bio says new research in lung cancer is warranted after this finding
News
Rise and Shine: Everything you need to know before the ASX opens
Explainers
ASX cancer stocks guide: Here’s everything you need to know
News
ASX Small Caps and Weekly IPO Wrap: Tech, Telcos and Money do well in a positive week overall
News
Rise and Shine: Everything you need to know before the ASX opens
News
CLOSING BELL: Hump Day is Slump Day yet again, as the ASX drops another 0.46%
News
In Case You Missed It: Cancer fighters, Kalahari copper and corporate travel on the rise
News
ASX Small Caps Lunch Wrap: Who else is probably going to regret the jokes they told this morning?
Health & Biotech
ASX Health Stocks: Rhythym Bio skyrockets 70pc after being granted UK CA Mark
Health & Biotech
ASX Health Stocks: Control Bionics launches world’s first autonomous driving wheelchair, DROVE
Health & Biotech
ASX Health Stocks: Noxopharm plunges 45pc after discontinuing Veyonda clinical trials
News
